Skip to main content
. 2020 Aug 12;36(6):580–590. doi: 10.1007/s12055-020-00982-5

Table 7.

Independent risk factors of mortality

Characteristics In-hospital mortality univariate logistic regression Mortality within the follow-up univariate proportional hazard regression
Odds ratios with 95%CI p value Hazard ratios with 95%CI p value
Preoperative
Age [years] 1.06 (1.01–1.1) 0.01 1.07 (1.05–1.09) < 0.001
Cardiopulmonary resuscitation 2.85 (1.02–7.97) 0.046 2.86 (1.7–4.8) < 0.001
Severe shock 2.24 (1.26–3.99) 0.006 1.43 (1.1–1.9) 0.006
ST-elevation myocardial infarction (STEMI) 3.53 (1.5–8.1) 0.003 1.3 (0.8–2.2) 0.345
Non-ST-elevation myocardial infarction (NSTEMI) 0.92 (0.4–2.0) 0.830 1.64 (1.1–2.5) 0.018
No biochemical criteria for myocardial injury 0.23 (0.1–0.97) 0.046 0.4 (0.23 to 0.7) 0.001
eGFR [ml/min] 0.97 (0.96–0.99) < 0.001 0.98 (0.98–0.99) < 0.001
Atrial fibrillation 1.43 (0.85–2.43) 0.174 1.6 (1.3–2) < 0.001
Number of narrowed coronary vessels 1.01 (0.56–2.15) 0.785 1.12 (0.8–1.58) 0.509
Active infection 5.3 (2.1–13.5) < 0.001 2.56 (1.5–4.4) 0.001
Stenosis of left main coronary artery 1.07 (0.51–2.23) 0.87 1.04 (0.73–1.49) 0.82
Intraoperative
CPB time [min] 1 (0.99–1.004) 0.37 1 (0.999–1.005) 0.201
Cross-clamp time [min] 1 (0.99–1) 0.051 1 (0.992–1.006) 0.81
Postoperative
Bypass revision 5.03 (0.97–26) 0.054 1.6 (0.51–5.04) 0.419
IABP 1.21 (0.95–1.54) 0.127 1.03 (0.82–0.29) 0.822
Length of noradrenaline support [days] 1.05 (0.94–1.17) 0.421 0.95 (0.88–1.03) 0.201
Length of dobutamine support [days] 1.03 (0.95–1.11) 0.538 0.98 (0.93–1.03) 0.41
Length of adrenaline support [days] 1.02 (0.86–1.2) 0.819 0.97 (0.88–1.07) 0.569
Length of mechanical ventilation [hours] 1 (0.997–1.006) 0.482 1 (0.996–1.002) 0.444
Delirium 1.33 (0.53–3.34) 0.549 1.1 (0.69–1.76) 0.689
Stroke 2.12 (0.46–9.7) 0.335 2.24 (1.04–4.8) 0.039
Gastrointestinal bleeding 4.9 (2.04–11.97) < 0.001 1.35 (0.74–2.44) 0.324

significant p-values are presented in italic